Fast Five Quiz: Do You Know the Conditions Associated With Menopause and How Best to Treat Them?

Michel E. Rivlin, MD


January 20, 2015

With proper intervention, osteoporosis is a largely preventable sequela of menopause. Bisphosphonates (alendronate, etidronate, ibandronate, risedronate, and zoledronic acid) are the most useful pharmacologic intervention. Most of them prevent vertebral fractures, as do raloxifene and estrogen; however, raloxifene and estrogen have been shown to increase risk for thromboembolic events. Some bisphosphonates (alendronate, risedronate, and zoledronic acid) prevent hip and other nonvertebral fractures.

For more on osteoporosis as a sequela of menopause, read here.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.